original ) (raw )Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011
Antonia Boman
Scandinavian Journal of Rheumatology, 2020
View PDFchevron_right
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
Gabriella Morozzi , E. Bartoloni , Nicola Bizzaro , vittorio bini , Claudia Alpini , Marilina Tampoia
Arthritis Research & Therapy, 2013
View PDFchevron_right
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset
Ewa Berglin
Annals of the Rheumatic Diseases, 2006
View PDFchevron_right
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
Anya Burton , Nynke Smidt
Annals of Internal Medicine, 2010
View PDFchevron_right
Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis
Onelia Bistoni
Joint Bone Spine, 2017
View PDFchevron_right
Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
Omer Kuru
Bratislavské lekárske listy, 2009
View PDFchevron_right
Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis
Sabahat Aksaray
Clinical Rheumatology, 2006
View PDFchevron_right
Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis
Karen Costenbader
The Journal of Rheumatology, 2009
View PDFchevron_right
Correlation between anti-cyclic citrullinated peptide antibodies and the severity of clinical manifestation, laboratory manifestation, and radiological joint destruction in rheumatoid arthritis patients
Handono KALIM
Indonesian Journal of Rheumatology, 2018
View PDFchevron_right
The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis
M. Cader , Karim Raza
BMC Musculoskeletal Disorders, 2010
View PDFchevron_right
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
ioanna marinou
Arthritis research & therapy, 2006
View PDFchevron_right
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
matthew liang
Annals of Internal Medicine, 2007
View PDFchevron_right
The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
Behzad Heidari
Annals of Saudi Medicine, 2009
View PDFchevron_right
The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
T. Uhlig
Arthritis Research & Therapy, 2010
View PDFchevron_right
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
Per-johan Jakobsson
Arthritis & Rheumatism, 2013
View PDFchevron_right
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis
P. Caroline Gordon
The Journal of rheumatology, 2005
View PDFchevron_right
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
J. Avouac
Annals of the Rheumatic Diseases, 2005
View PDFchevron_right
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study
Per Gaarder
Annals of the Rheumatic Diseases, 2008
View PDFchevron_right
THE DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES (anti-CCP) IN PATIENTS WITH RHEUMATOID ARTHRITIS DIJAGNOSTI^KO ZNA^ENJE ANTI-CIKLI^NIH CITRULINIRANIH PEPTIDNIH ANTITELA (anti-CCP) KOD PACIJENATA SA REUMATOIDNIM ARTRITISOM
Ljubinka Damjanovska
2007
View PDFchevron_right
Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis
Wilton F S Santos
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.], 2008
View PDFchevron_right
Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis
Bardia Jamali
Rheumatology International, 2012
View PDFchevron_right
Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
Mario Salazar-paramo , Arnulfo Hernán Nava-Zavala
BioMed Research International, 2014
View PDFchevron_right
Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Subjects at Increased Risk of Rheumatoid Arthritis and Subjects With Established Disease
Jan Hughes-austin
Arthritis & Rheumatism, 2013
View PDFchevron_right
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
Mahmood Ally , Pieter Meyer , Mohammed Tikly
BMC Musculoskeletal Disorders, 2015
View PDFchevron_right
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis
Yukihiko Saeki
Clinical Rheumatology, 2007
View PDFchevron_right
Anti–Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze
matthew liang
Annals of Internal Medicine, 2007
View PDFchevron_right
Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
imane kaddouri
Rheumatology International, 2007
View PDFchevron_right
Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
Jacqueline Dekkers
Archives of Medical Science, 2011
View PDFchevron_right
Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis
Ahmed Saad
Modern Rheumatology, 2010
View PDFchevron_right